Johnson & Johnson Ordered to Pay $344 Million for Selling Transvaginal Mesh Implants Despite Known Health Risks

As reported by Law360 (subscription), a California federal judge has ruled that Johnson & Johnson must pay nearly $344 million in civil penalties for misleading consumers about the true health risks associated with its pelvic mesh products. The trailblazing suit was brought by California’s attorney general, Xavier Becerra, who in a statement touting the judge’s

2020-01-31T14:08:29+00:00January 31st, 2020|Personal Injury, Women's Health|

Lieff Cabraser donates goods to Youth Villages of Middle Tennessee

Lieff Cabraser is proud to announce that it has organized an office building-wide drive to collect much-needed household goods for children in need at Youth Villages of Middle Tennessee. The successful drive resulted in the donation of several truckloads of goods including household items, clothing, books, and games. Youth Villages is a national organization that

2020-01-29T12:01:12+00:00January 29th, 2020|Firm News, Public Good|

Lieff Cabraser Announces Notice of Settlement for Anticoagulant Medications Lovenox® and Generic Enoxaparin

If You Bought or Provided Reimbursement for the Anticoagulant Medications Lovenox® or Generic Enoxaparin Between September 21, 2011 and September 30, 2015 You Could Get Money from Class Action Settlements Totaling $120 Million Proposed Settlements totaling $120 million have been reached in a class action lawsuit regarding the price that uninsured consumers, hospitals, and third-party

2020-01-25T07:40:20+00:00January 25th, 2020|Antitrust|

David Stellings Discusses Plaintiff Perspectives on Multidistrict Litigation at University of Miami School of Law Class Action Forum

On January 24, 2020, Lieff Cabraser partner David S. Stellings spoke at The University of Miami School of Law’s 2020 “Class Action & Complex Litigation Forum.” David and several other legal experts were featured on the panel “MDL—Who Wants One? Plaintiff, Defense and Judicial Perspectives on MDL Pros and Cons.”

2020-01-24T13:51:40+00:00January 24th, 2020|Firm News|

Lieff Cabraser Files Amicus Brief in U.S. Supreme Court Supporting the SEC’s Ability to Seek Disgorgement of Gains from Securities Law Violations in Federal Court

Lieff Cabraser today filed an amicus brief in the U.S. Supreme Court arguing for the importance of the ability of the Securities and Exchange Commission to continue to seek disgorgement of the gains from securities law violations in federal court in order to effectively deter securities fraud and promote the public policies that form the

2020-01-22T08:17:51+00:00January 22nd, 2020|Amicus, Securities Fraud|